Designing clinical trials for early (pre-dementia) Alzheimer's disease: Determining the appropriate population for treatment

Journal of Nutrition, Health and Aging

Volumn 15, Issue 1, 2011, Pages 22-24

  Siemers, E ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BREAST CANCER; CANCER SCREENING; CARDIOVASCULAR DISEASE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; COLON CANCER; CONTROLLED STUDY; DISEASE COURSE; GENETIC SCREENING; HUMAN; HUNTINGTON CHOREA; MILD COGNITIVE IMPAIRMENT; MORTALITY; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 85027933152     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-011-0008-6     Document Type: Article

References (22)

1. G. McKhann D. Drachman M. Folstein R. Katzman D. Price E.M. Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease Neurology 34 939 944 1:STN:280:DyaL2c3ks1altQ%3D%3D 6610841 (Pubitemid 14076461)
2. H. Amieva M. Le Goff X. Millet J.M. Orgogozo K. Peres P. Barberger-Geteau H. Jacqmin-Gadda J.F. Dartigues 2008 Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms Ann Neurol 64 492 498 10.1002/ana.21509 19067364
3. R.C. Petersen J.C. Stevens M. Ganguli E.G. Tangalos J.L. Cummings S.T. DeKosky 2001 Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56 1133 1142 1:STN:280:DC%2BD3MzntFansQ%3D%3D 11342677
4. B. Dubois H.F. Feldman C. Jacova S.T. DeKosky, et al. 2007 Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 6 734 746 10.1016/S1474-4422(07)70178-3 17616482 (Pubitemid 47058377)
5. M. Grundman R.C. Petersen D. Bennett, et al. 2006 Alzheimer Association Research Roundtable Meeting on Mild Cognitive Impairment: What have we learned? Alzheimer's and Dementia 2 220 233 10.1016/j.jalz.2006.04.010 19595891 (Pubitemid 43869451)
6. http://clinicaltrials.gov/ct2/show/NCT00890890
7. ADAPT Research Group. 2007 Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial Neurology 68 1 9 10.1212/01.wnl.0000260269.93245.d2 (Pubitemid 46791392)
8. M.R. Hayden 2003 Predictive testing for Huntington's disease: a universal model? Lancet Neurol 2 141 142 10.1016/S1474-4422(03)00317-X 12849232 (Pubitemid 37443316)
9. Cholesterol Treatment Trialist Collaborators. 2005 Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267 1278 10.1016/S0140-6736(05)67394-1 (Pubitemid 41416582)
10. Weinberg DS. In the clinic: Colorectal cancer screening. Ann Intern Med 2008:ICT1-ICT16.
11. B. Levin D.A. Lieberman B. McFarland K.S. Andrews, et al. 2008 Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on colorectal cancer, and the American College of Radiology Gastroenterology 134 1570 1595 1:CAS:528:DC%2BD1cXntVWgs74%3D 10.1053/j.gastro.2008.02.002 18384785 (Pubitemid 351615355)
12. S. Subramanian G. Bobashev R.J. Morris 2009 Modeling the cost-effectiveness of colorectal cancer screening: Policy guidance based on pateint preferences and compliance Cancer Epidemiol Biomarkers Prev 18 1971 1978 10.1158/1055-9965.EPI-09-0083 19567507
13. L. Esserman Y. Shieh I. Thompson 2009 Rethinking screening for breast cancer and prostate cancer JAMA 302 1685 1692 1:CAS:528:DC%2BD1MXhtlWqs7%2FO 10.1001/jama.2009.1498 19843904
14. A. Qaseem V. Snow K. Sherif, et al. 2007 Screening mammography for women 40 to 49years of age: A clinical practice guideline from the American College of Physicians Ann Intern Med 146 522 525
15. J.S. Mandelblatt C.B. Schechter R. Vabroff, et al. 2005 Toward optimal screening strategies for older women: Costs, benefits, and harms of breast cancer screening aby age, biology and health status J Gen Intern Med 20 487 496 10.1111/j.1525-1497.2005.0116.x 15987322 (Pubitemid 41007065)
16. U.S. Preventive Services Task Force. 2009 Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 151 716 726
17. M.J. Barry 2009 Screening for prostate cancer - the controversy that refuses to die NEJM 360 1351 1354 1:CAS:528:DC%2BD1MXjs1SisLw%3D 10.1056/NEJMe0901166 19297564
18. F.H. Schroder J. Hugosson M.J. Roobol, et al. 2009 Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 1320 1328 10.1056/NEJMoa0810084 19297566
19. G.L. Andriole R.L. Grubb S.S. Buys, et al. 2009 Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 1310 1319 1:CAS:528:DC%2BD1MXjs1ejsLk%3D 10.1056/NEJMoa0810696 19297565
20. Kahle-Wrobleski K, Siemers ER, Callahan CM, Sarpong EM, Furiak NM, Klein TM, Klein RW. Biomarker Screening for Alzheimer's Disease: The Impact of Sensitivity and Specificity Parameters. American Academy of Neurology 2009 annual meeting, Seattle, WA; P09. 119.
21. K. Kahle-Wrobleski N. Furiak R. Klein T. Klein E. Siemers 2009 Biomarker screening for Alzheimer's disease: When to screen and how often? Alzheimer's & Dementia 5 P15 10.1016/j.jalz.2009.05.046
22. O. Hansson H. Zetterberg P. Buchhave E. Londos K. Blennow L. Minthon 2006 Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study Lancet Neurol 5 228 234 1:CAS:528:DC%2BD28XisF2qsbg%3D 10.1016/S1474-4422(06)70355-6 16488378 (Pubitemid 43238346)